aqst stock forecast

at $4.87 per share.Derivative/Non-derivative trans.

9:22 a.m. May 27, 2020 - Zacks.com. Our site uses a custom algorithm based on Deep Learning that helps our users to decide if This means that if you invested $100 now, your current investment may be worth This means that this stock is not suited as a new addition to your portfolio as trading in bear markets, especially for less experienced traders, is always harder.

The firm also collaborates with pharmaceutical partners to bring new molecules to market in differentiated and highly-marketable dosage forms. AQST Aquestive Therapeutics $5.48 / -0.19 (-3.35%) 07/02/20 Aquestive CEO sees near-term value driven by CNS/epilepsy franchise 07/02/20 Kendall sees potential value inflection points coming for Aquestive shareholders 07/02/20 Aquestive CEO sees 'no reason' to believe Libervant PDUFA will be delayed 07/02/20 Aquestive CEO says AQST-108 on track, PK trials to commence this year.

Stock Ideas.

at $3.73 per share.Aquestive Therapeutics started at outperform with $33 stock price target at WedbushAquestive Therapeutics shares jump 5.7% in trading debutAquestive Therapeutics prices upsized IPO at $15, midpoint of $14 to $16 range at $4.86 per share.Derivative/Non-derivative trans. The company was founded in January 2004 and is headquartered in Warren, NJ. Get the latest Aquestive Therapeutics Inc AQST detailed stock quotes, stock …

at $4.87 per share.Derivative/Non-derivative trans. 9:12 a.m. May 22, 2020 - …

View Aquestive Therapeutics Inc AQST investment & stock information. The trend analysis tool will help you make a better prediction on the AQST stock. Long Ideas; IPO Analysis; Quick Picks and Lists; Fund Letters; Closed End Funds; Stock Ideas by Sector ; Stock Ideas Editors Picks; Short Ideas; Dividends. Aquestive Therapeutics, Inc. is a specialty pharmaceutical company focused on identifying, developing, and commercializing differentiated products to address unmet medical needs. *Stock price forecasts are predicted by Deep Learning processes by technical analysis, shouldn't been used for investment decision. at $2.19 per share.Derivative/Non-derivative trans.

View Aquestive Therapeutics' (NASDAQ:AQST) earnings history, next earnings date and earnings forecasts from top-rated Wall Street analysts at MarketBeat. Its product candidates include Libervant, Sympazan, and AQST-117 (Riluzole). The Aquestive Therapeutics, Inc. stock forecast is 0.000000 USD for 2021 August 07, Saturday with technical analysis. Aquestive Therapeutics, Inc. Common Stock (AQST) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. {"OrganizationDocuments":[{"Documents":[{"document":[{"reportDateGroup":[{"reportDate":"2011-06-09","tradeTypeGroup":[{"numTransactions":"5","tradeType":"A"}]},{"reportDate":"2011-05-17","tradeTypeGroup":[{"numTransactions":"3","tradeType":"D"},{"numTransactions":"1","tradeType":"A"}]},{"reportDate":"2011-05-16","tradeTypeGroup":[{"numTransactions":"2","tradeType":"D"},{"numTransactions":"8","tradeType":"A"}]},{"reportDate":"2011-05-13","tradeTypeGroup":[{"numTransactions":"1","tradeType":"D"}]},{"reportDate":"2011-05-12","tradeTypeGroup":[{"numTransactions":"1","tradeType":"D"}]},{"reportDate":"2011-05-11","tradeTypeGroup":[{"numTransactions":"1","tradeType":"D"}]},{"reportDate":"2011-05-02","tradeTypeGroup":[{"numTransactions":"1","tradeType":"D"}]},{"reportDate":"2011-03-10","tradeTypeGroup":[{"numTransactions":"5","tradeType":"A"}]},{"reportDate":"2011-02-17","tradeTypeGroup":[{"numTransactions":"4","tradeType":"D"},{"numTransactions":"2","tradeType":"A"}]},{"reportDate":"2011-02-15","tradeTypeGroup":[{"numTransactions":"8","tradeType":"A"},{"numTransactions":"1","tradeType":"D"}]}]}]}]}]}Derivative/Non-derivative trans.

QQQ 271.47 (-1.15%) AAPL 444.45 (-2.45%) MSFT 212.48 (-1.79%) FB 268.44 … In addition to its proprietary product candidates, the company, with its partners, has a portfolio of development-stage products and commercialized products, such as Suboxone, a prescription medicine for the treatment of opioid dependence.

AQST Stock Forecast - Get a free AQST stock predictions and find out whether you should buy or sell AQST stock. View Aquestive Therapeutics' (NASDAQ:AQST) earnings history, next earnings date and earnings forecasts from top-rated Wall Street analysts at MarketBeat. Copyright © 2020 MarketWatch, Inc. All rights reserved. Past success does not guarantee future profit !

Aquestive Therapeutics, Inc. is a specialty pharmaceutical company focused on identifying, developing, and commercializing differentiated products to address unmet medical needs. !PS Business Parks Inc. Depositary Shs Repr 1/1000th 4.875% Cum Perp Red Pfd Rg Shs Series Z Aquestive Therapeutics develops and delivers drugs via its PharmFilm technology. The company has a late-stage proprietary product pipeline focused on the treatment of Central nervous system (CNS) diseases, as well as orally-administered complex molecules that can be alternatives to invasively-administered standard of care therapies.